SOTERA HEALTH COMPANY Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 0.00 shares.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 0.00 shares.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 0.00 shares.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 30.95K shares.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
- SOTERA HEALTH COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 10.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 30.95K shares 10-K · filed 2026-02-24 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2024-02-27 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 0.00 shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 10.00 shares derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 10.00 shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-05 | 10.00 shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 10.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 10.00 shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |